Does SARILUMAB Cause Product dose omission issue? 548 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 548 reports of Product dose omission issue have been filed in association with SARILUMAB (KEVZARA). This represents 2.6% of all adverse event reports for SARILUMAB.
548
Reports of Product dose omission issue with SARILUMAB
2.6%
of all SARILUMAB reports
2
Deaths
45
Hospitalizations
How Dangerous Is Product dose omission issue From SARILUMAB?
Of the 548 reports, 2 (0.4%) resulted in death, 45 (8.2%) required hospitalization, and 1 (0.2%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SARILUMAB. However, 548 reports have been filed with the FAERS database.
What Other Side Effects Does SARILUMAB Cause?
Drug ineffective (5,065)
Pain (4,833)
Arthralgia (4,139)
Rheumatoid arthritis (3,963)
Joint swelling (3,951)
Condition aggravated (3,247)
Fatigue (3,000)
Rash (2,912)
Alopecia (2,660)
Abdominal discomfort (2,600)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which SARILUMAB Alternatives Have Lower Product dose omission issue Risk?
SARILUMAB vs SATRALIZUMAB
SARILUMAB vs SATRALIZUMAB-MWGE
SARILUMAB vs SAXAGLIPTIN
SARILUMAB vs SCHOLL'S INGROWN TOENAIL PAIN RELIEVER
SARILUMAB vs SCOPOLAMINE